Work

F2‐03‐02: Optimizing Cognitive Outcomes for Biomarker Positive Individuals at Different Clinical Stages of Alzheimer's Disease According to the Nia‐aa Research Framework

Year: 2019

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2019.06.4425

Authors: Roos J. Jutten, Sietske A.M. Sikkes, Rebecca Amariglio, Rachel F. Buckley, Michael J. Properzi, Gad A. Marshall, Dorene M. Rentz, Keith A. Johnson, Wiesje M. van der Flier, Philip Scheltens, Reisa A. Sperling, Kate V. Papp

Institutions: Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Harvard University, Massachusetts General Hospital, Brigham and Women's Hospital

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2981131823

FWCI:

Cites:

Cited by:

Related to: 10